Not a healthcare professional? Go to the patient or caregiver website.

VYNDAQEL® OR VYNDAMAX™ Indications and Usage (tafamidis meglumine or tafamidis)

1. INDICATIONS AND USAGE

VYNDAQEL and VYNDAMAX are indicated for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular mortality and cardiovascular-related hospitalization.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No